Have a question or want to speak with a team member?
Stay updated on our progress in changing the landscape of ovarian cancer treatment options and outcomes.
Nov 18, 2020
OvCAN Patient Partners inform research with their lived experience
OvCAN Patient Partners have important roles in a wide range of activities, from reviewing clinical trial funding applications to sharing their lived experience directly with ovarian cancer researchers and scientists.
Nov 2, 2020
Researchers examine new drug target with potential to improve treatment
Dr. Kirk McManus and Dr. Mark Nachtigal's collaborative research project was recently awarded two years’ joint funding from Ovarian Cancer Canada and the Cancer Research Society.
Sep 23, 2020
Making Waves in Research: OvCAN Update
Four OvCAN-funded clinical trials happening across Canada will provide a wide range of new insights.
May 27, 2020
Paving the way for research breakthroughs
Allen Zhang receives 2020 Anita Unruh Prize
Nov 27, 2019
Getting to Know Alicia Tone, Scientific Advisor
While advancing research and treatment options for women diagnosed or at risk of the disease is a critical priority, exploring and informing women about disease prevention is also important to us.
Sep 26, 2019
PARP Inhibitors 101 – New hope for the treatment of ovarian cancer
PARP inhibitors (PARPi) are a new family of drugs being used in the treatment of ovarian cancer.
Mar 19, 2019
Mar 19, 2019
Press Release – Budget 2019
Ovarian Cancer Canada Welcomes Long-Sought Investments in Research Funding
Sep 19, 2018
McGill researcher receives the Pat McDonald Research Award
Little is known about how high-grade serous ovarian cancer develops. But that’s set to change, if Dr. Yojiro Yamanaka has anything to say about it.
Jun 26, 2018
Conference brings together women with ovarian cancer and researchers
As scientists, research trainees, and specialists gathered in Edmonton for the Canadian Conference on Ovarian Cancer Research, women and their families came from near and far to attend a concurrent workshop focused on survivorship.